LFG
VNRX icon

Larson Financial Group’s VolitionRx Ltd VNRX Stock Holding History

Larson Financial Group’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed -$120 – 2921
2024
Q3 		$120 Buy
+10
New +$129 ﹤0.01% 2502
2020
Q3 		– Sell
-118
Closed -$9K – 843
2020
Q2 		$9K Hold
118
– – ﹤0.01% 421
2020
Q1 		$7K Hold
118
– – ﹤0.01% 342
2019
Q4 		$11K Hold
118
– – 0.01% 292
2019
Q3 		$13K Buy
+118
New +$9.39K 0.01% 276

Other funds holding VNRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Larson Financial Group's VNRX Position: Q4 2024 in Review

Larson Financial Group sold out of VolitionRx Ltd (VNRX) in Q4 2024, closing a stake of 10 shares — an estimated $120 sold.

Larson Financial Group first reported a position in VNRX in Q3 2019 and held it in 5 quarters. The position peaked at $13K in Q3 2019. 27 funds tracked by Wall St. Rank hold VNRX as of Q4 2024.

  • Larson Financial Group reported no remaining VolitionRx Ltd position as of Q4 2024 after selling out during the quarter.
  • Larson Financial Group sold 10 VolitionRx Ltd shares in Q4 2024, an estimated $120.
  • Larson Financial Group first reported a position in VolitionRx Ltd in Q3 2019 and held it in 5 quarters.
  • Larson Financial Group's VolitionRx Ltd position peaked at $13K in Q3 2019.
  • 27 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2024.

Based on Larson Financial Group's 13F filing for Q4 2024, filed 7 Feb 2025.